Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2026-06-05 English
Updates
M&A Activity Classification · 90% confidence The document is a formal submission to stock exchanges under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, containing the Recommendation of the Committee of Independent Directors on an Open Offer for acquisition of equity shares by an acquirer. This falls squarely under takeover bid materials, i.e., M&A Activity related to a substantial acquisition of shares. It is not an earnings release, board change, regulatory filing certificate, or other category. Therefore, it should be classified as M&A Activity (Code: TAR).
2026-06-05 English
Rarever Financial Advisors Private Limited ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement cum Corrigendum to the public announcement and detailed public ....
Regulatory Filings
2026-06-05 English
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors on the Open Offer of Ortin Global ....
M&A Activity Classification · 90% confidence The document is an Indian stock exchange submission under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It contains the Recommendation of the Independent Directors’ Committee on an Open Offer (takeover bid) by an acquirer for shares of Ortin Global Limited. It is clearly a takeover/open offer communication, not a full annual or quarterly report, earnings release, or board change notice. Therefore it falls under M&A Activity (takeover bid filings).
2026-06-03 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 85% confidence The document is a stock‐exchange filing from Ortin Global Limited providing the outcome of its board meeting and enclosing the audited financial results for the quarter and year ended 31.03.2026. It includes comprehensive financial statements (statement of audited results, assets & liabilities, cash flows) and an auditor’s report—all hallmarks of a quarterly (interim) financial report rather than a short earnings highlight or full annual report. Under the defined categories, this is an Interim / Quarterly Report (IR). FY 2026
2026-05-30 English
Outcome of Board Meeting held on 30.05.2026
Interim / Quarterly Report Classification · 85% confidence The document is a statutory disclosure made under SEBI (LODR) Regulation 33 announcing the audited financial results “for the quarter and year ended 31.03.2026” following a Board meeting. It contains comprehensive financial statements (P&L, balance sheet, cash flow, notes) and the independent auditor’s report. While it covers full‐year audited results, it is not a full Annual Report (10-K) but rather the standalone audited periodical results. This fits the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.